Phreesia Inc. (NYSE:PHR) shares soared 5.01% on Wednesday during intraday trading, following the release of the company's better-than-expected third quarter fiscal 2025 results. The company reported a narrower net loss of $14.4 million, or $0.25 per share, beating analyst estimates by 11%.
Analysts were optimistic about Phreesia's growth prospects, with Truist raising its price target to $34 from $31 and maintaining a Buy rating. Baird also reiterated an Outperform rating on the stock. Analysts cited the company's strong revenue growth of 17% year-over-year and expectations for continued growth in the healthcare services industry.
However, some analysts highlighted risks related to Phreesia's global expansion plans, as the company may face legal hurdles and compliance costs in operating across different jurisdictions. Overall, the strong quarterly results and positive analyst commentary appear to be driving the stock's upward movement.
Comments